Latest News of AMG
Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
By Investor's Business Daily |
2 days ago
Amgen's high volatility presents an opportunity for iron condor setups. Selling Dec. 20 expiry puts and calls allows for a wide profit range. Risk is capped at $325 with profit potential of $175. Sett...
The 2025 Mercedes-AMG GT Coupe: Expensive German performance, a graceful package
By MarketWatch |
3 days ago
The 2025 Mercedes-AMG GT Coupe offers powerful performance options, expected to start at $120,000....
The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period
By Yahoo! Finance |
5 days ago
Amgen Inc. (NASDAQ: AMGN) shareholders saw a 13% drop in share price last week, yet the company's three-year returns were strong at 38%, surpassing the market index. Despite a decline in earnings per ...
-
Amgen speaks out about bone density concerns with obesity drug
By Yahoo! Finance | 1 week agoAmgen responded to concerns over bone density loss in its obesity drug candidate, MariTide, following an analyst's comments that caused a market drop. The company stated no association with BMD change...
-
Stocks making the biggest moves midday: Rivian, Cava, Rocket Lab, Amgen and more
By CNBC | 1 week agoCharter Communications acquires Liberty Broadband, Cava Group's stock rises on strong earnings, Rocket Lab's revenue soars, and Maplebear's shares tumble. Skyworks Solutions and SoundHound AI post wea...
-
Amgen Says No Link Between MariTide, Bone Density Loss
By MarketWatch | 1 week agoAmgen addresses concerns over potential bone density loss linked to MariTide weight-loss shot. Despite stock decline, company sees no safety risk and remains committed to MariTide. Phase 2 study resul...
-
Amgen stock falls as analysts mull over weight loss drug's bone density data
By CNBC | 1 week agoAmgen's MariTide injection for weight loss caused a 7% stock drop due to concerns over bone density loss. Analysts debated its safety risk, with some calling it an overreaction and others urging more ...
-
Amgen Drops 7% After A 'Big, Unknown Risk' Rattles Obesity Shot
By Investor's Business Daily | 1 week agoAmgen's stock fell due to concerns about MariTide's impact on bone mineral density. Analysts remain optimistic but acknowledge risks. Amgen's weight-loss shot faces competition from Novo Nordisk and E...
-
AMG Critical Materials Third Quarter 2024 Earnings: US$0.41 loss per share (vs US$0.01 profit in 3Q 2023)
By Yahoo! Finance | 1 week agoThe chart displays trailing 12-month figures. AMG Critical Materials is predicted to have 9.7% revenue growth annually for the next 3 years, outperforming the European Metals and Mining industry. Watc...
-
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
By Yahoo! Finance | 1 week agoTezspire has shown significant reduction in nasal polyp size and congestion in a study. It's being evaluated for severe chronic rhinosinusitis with nasal polyps and approved for severe asthma. Further...
-
Affiliated Managers Group Inc (AMG) Q3 2024 Earnings Call Highlights: Record AUM and Strategic ...
By Yahoo! Finance | 2 weeks agoAMG's focus is on capital deployment in private markets and liquid alternatives to capture secular growth trends. They plan $700 million in share repurchases in 2024 while remaining flexible for growt...
-
Is Amgen Inc. (AMGN) the Best Pharma Stock to Buy Right Now?
By Yahoo! Finance | 2 weeks agoThe pharmaceutical industry is witnessing a shift towards weight-loss drugs like Ozempic and Wegovy, showing potential in treating addiction and conditions like Alzheimer's. Despite challenges like fu...
-
Affiliated Managers Group, Inc. (AMG) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 2 weeks agoAMG released its financial results for Q3 and nine months ending on September 30, 2024. They reported an EPS of $3.78, Economic EPS of $4.82, with net income of $124 million. Additionally, they repurc...
-
Silvercrest Asset Management Group (NASDAQ:SAMG) Will Pay A Dividend Of $0.20
By Yahoo! Finance | 2 weeks agoSilvercrest Asset Management Group Inc. (NASDAQ:SAMG) is set to pay investors $0.20 per share on December 20th, exceeding industry standards. Despite a history of stable dividends, recent earnings dec...
-
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
By Yahoo! Finance | 2 weeks agoAmgen Inc's recent 10-Q filing reveals a strong financial performance with increased product sales driven by volume growth and strategic acquisitions. The company's resilience in navigating challenges...